Pantheon Bioscience develops groundbreaking molecular tools based on new anti-phage defense systems discovered by Professor Rotem Sorek at the Weizmann Institute of Science, Israel. Understanding the mechanisms of action of these new systems will potentially result in disruptive tools for biotechnological applications. Pantheon Bioscience is supported by Explore Bio, a pre-seed investment initiative for early-stage investments in Israeli biotech companies. Cornerstone investors in the Explore Bio program include M Ventures, Arkin Bio Ventures, Pontifax and WuXi AppTech. Pantheon Bioscience was founded in 2018 and is based in the M Ventures BioIncubator at Inter-Lab, Yavne, Israel.